0.2739
price up icon1.26%   0.0034
 
loading

Finanzdaten der Athira Pharma Inc-Aktie (ATHA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Research and Development
10.32%
21.24
23.68 27.20 21.61 21.29
Costs And Expenses
4.57%
27.69
29.01 35.04 31.64 29.77
Operating Income/Loss
4.57%
-27.69
-29.01 -35.04 -31.64 -29.77
Income/Loss From Continuing Operations Before Tax
3.47%
-26.34
-27.29 -35.04 -29.60 -27.82
Income/Loss From Continuing Operations After Tax
3.47%
-26.34
-27.29 -32.97 -29.60 -27.82
Net Income/Loss
3.47%
-26.34
-27.29 -32.97 -29.60 -27.82
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
140.89K%
38.32
0.0272 38.05 38.00 37.92
Diluted Average Shares
140.89K%
38.32
0.0272 38.05 38.00 37.92
Basic Earnings Per Share
2.82%
-0.69
-0.71 -0.87 -0.78 -0.73
Diluted Earnings Per Share
2.82%
-0.69
-0.71 -0.87 -0.78 -0.73
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$1.16
price down icon 17.27%
$31.18
price down icon 3.94%
$578.71
price down icon 0.54%
$286.89
price down icon 0.52%
$4.10
price down icon 2.24%
$72.94
price down icon 0.11%
Kapitalisierung:     |  Volumen (24h):